Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H.

about

Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Membrano-proliferative glomerulonephritis, atypical hemolytic uremic syndrome, and a new complement factor H mutation: report of a case.

P2860

Q33401403-8E496598-FBE8-4B2C-A23B-5C395ABECA98 Q33401621-7535B6A8-32C8-4505-81FA-68986D9D3148

P2860

Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H.

Item

http://www.wikidata.org/entity/Q51714954

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Actual and future strategies f ...... ed with mutations in factor H.

@en

Actual and future strategies f ...... ed with mutations in factor H.

@nl

type

Item

label

Actual and future strategies f ...... ed with mutations in factor H.

@en

Actual and future strategies f ...... ed with mutations in factor H.

@nl

prefLabel

Actual and future strategies f ...... ed with mutations in factor H.

@en

Actual and future strategies f ...... ed with mutations in factor H.

@nl

P1476

Actual and future strategies f ...... ed with mutations in factor H.

@en

P2093

Alejandra Rosales

http://www.w3.org/2001/XMLSchema#string

Lothar Bernd Zimmerhackl

http://www.w3.org/2001/XMLSchema#string

Magdalena Riedl

http://www.w3.org/2001/XMLSchema#string

Therese Jungraithmayr

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations in components of complement influence the outcome of Factor I-associated atypical hemolytic uremic syndrome

The risk of recurrence of hemolytic uremic syndrome after renal transplantation in children.

Attempted treatment of factor H deficiency by liver transplantation.

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

Hemolytic uremic syndrome: a fatal outcome after kidney and liver transplantation performed to correct factor h gene mutation.

Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation.

Renal transplantation in HUS patients with disorders of complement regulation.

Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome.

Outcome of renal transplantation in patients with non-Shiga toxin-associated hemolytic uremic syndrome: prognostic significance of genetic background.

Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome

P304

225-228

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1111/J.1399-3046.2010.01345.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21492349

http://www.w3.org/2001/XMLSchema#string

Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H.

about

P2860

P2860

Actual and future strategies for transplantation in atypical HUS associated with mutations in factor H.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698